Daiwa Securities Group
NRC icon

Daiwa Securities Group’s NRC Health Common Stock NRC Stock Holding History

Daiwa Securities Group’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$337K Sell
19,836
-2,400
-11% -$40.8K ﹤0.01% 966
2025
Q4 		$417K Sell
22,236
-2,875
-11% -$43.4K ﹤0.01% 926
2025
Q3 		$321K Sell
25,111
-857
-3% -$12.9K ﹤0.01% 942
2025
Q2 		$436K Sell
25,968
-5,000
-16% -$67.5K ﹤0.01% 889
2025
Q1 		$396K Sell
30,968
-2,000
-6% -$32.1K ﹤0.01% 872
2024
Q4 		$582K Hold
32,968
– – ﹤0.01% 809
2024
Q3 		$754K Sell
32,968
-4,500
-12% -$102K ﹤0.01% 777
2024
Q2 		$860K Sell
37,468
-1,200
-3% -$37K ﹤0.01% 739
2024
Q1 		$1.53M Buy
38,668
+4,350
+13% +$172K 0.01% 618
2023
Q4 		$1.36M Sell
34,318
-5,300
-13% -$222K 0.01% 618
2023
Q3 		$1.76M Sell
39,618
-6,084
-13% -$265K 0.01% 529
2023
Q2 		$1.99M Sell
45,702
-2,800
-6% -$123K 0.01% 501
2023
Q1 		$2.11M Sell
48,502
-4,300
-8% -$190K 0.01% 477
2022
Q4 		$1.97M Sell
52,802
-3,000
-5% -$116K 0.02% 483
2022
Q3 		$2.22M Sell
55,802
-8,000
-13% -$296K 0.02% 430
2022
Q2 		$2.44M Sell
63,802
-5,000
-7% -$181K 0.02% 404
2022
Q1 		$2.73M Hold
68,802
– – 0.02% 413
2021
Q4 		$2.86M Hold
68,802
– – 0.02% 407
2021
Q3 		$2.9M Buy
68,802
+9,000
+15% +$453K 0.02% 383
2021
Q2 		$2.75M Buy
59,802
+14,200
+31% +$675K 0.02% 374
2021
Q1 		$2.14M Sell
45,602
-17,200
-27% -$836K 0.02% 401
2020
Q4 		$2.69M Buy
62,802
+2,702
+4% +$139K 0.02% 324
2020
Q3 		$2.96M Buy
60,100
+15,554
+35% +$861K 0.03% 255
2020
Q2 		$2.03M Hold
44,546
– – 0.04% 227
2020
Q1 		$2.03M Buy
44,546
+24,346
+121% +$1.46M 0.02% 315
2019
Q4 		$1.33M Buy
+20,200
New +$1.23M 0.01% 444

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Daiwa Securities Group's NRC Position: Q1 2026 in Review

Daiwa Securities Group reduced its NRC Health Common Stock (NRC) stake by 11% in Q1 2026, selling an estimated $40.8K and leaving 19,836 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #966.

Daiwa Securities Group first reported a position in NRC in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.96M in Q3 2020. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Daiwa Securities Group held 19,836 shares of NRC Health Common Stock worth $337K as of Q1 2026.
  • Daiwa Securities Group sold 2,400 NRC Health Common Stock shares in Q1 2026, an estimated $40.8K.
  • NRC Health Common Stock made up ﹤0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #966 holding.
  • Daiwa Securities Group first reported a position in NRC Health Common Stock in Q4 2019 and has held it in 26 quarters since.
  • Daiwa Securities Group's NRC Health Common Stock position peaked at $2.96M in Q3 2020.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.